The Food and Drug Administration issued a warning in June 2011 that diabetic patients who have taken Actos and other pioglitazone-containing medicines are at a higher risk of developing bladder cancer. The warning notes that the risk is higher in patients who have taken higher dosages of Actos for more than 12 months.
France has stopped the release of these drugs. The FDA noted that it was aware of France’s decision. However, the FDA has not banned these medicines from being issued in the United States.
Gersowitz Libo & Korek, P.C. has been researching patients who have developed bladder cancer as a result of taking Actos and is now accepting new clients. If you or a loved one has fallen victim to the drug Actos, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997 to learn your legal rights.
Driver Charged With DWI After Teen Seriously Injured in West Babylon Collision WEST BABYLON, NEW…
Medical Helicopter Transported Pedestrian After They Were Hit By Left-Turning Vehicle Near Ponquogue Avenue and…
Elderly Pedestrian Seriously Injured In Central Islip Pedestrian Collision Involving Jeep at Intersection With a…
Driver May Have Suffered Medical Emergency Before 10-Vehicle Collision on the Southern State Parkway in…
NYPD Investigating Fatal Tractor-Trailer Collision on the Trans-Manhattan Expressway at the George Washington Bridge MANHATTAN,…
NYPD Investigating Fatal Ambulance Accident Involving Cyclist in Staten Island's Graniteville Neighborhood STATEN ISLAND, NEW…